Skip to main content

Find Clinical Trials

Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,408 public trials 1,309 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone

NCT02875821

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Yonsei University College of Medicine, Department of internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center Seoul, South Korea

View Trial Details

Completed

An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

NCT00467545

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Novartis Investigative Site (705-035) Daegu, South Korea

Novartis Investigative Site , (420-717) Gyeonggi-do, South Korea

Novartis Investigative Site , (405-760) Incheon, South Korea

Novartis Investigative Site , (136-705) Seoul, South Korea

View Trial Details

Completed

Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement

NCT02784925

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases
Locations: Not specified

View Trial Details

Completed

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

NCT00646503

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Novartis Investigative Site Beijing, China

View Trial Details

Completed

SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection

NCT01962441

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Riverside, California, United States

San Diego, California, United States

San Francisco, California, United States

Aurora, Colorado, United States

View all 78 locations

View Trial Details

Completed

Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly

NCT01457495

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Not specified

View Trial Details

Completed

Non-invasive Liver Screening for Risk Assessment for Coronary Heart Disease

NCT02779946

Conditions: Cardiovascular Diseases, Coronary Disease, Digestive System Diseases, +8 more
Locations: Leipzig University Medical Center Leipzig, Germany

View Trial Details

Completed

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately

NCT01457508

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Not specified

View Trial Details

Completed

Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

NCT00128544

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Pokfulam, Hong Kong

Auckland, New Zealand

Singapore

View Trial Details

Completed

The Relationship Between MDSCs and NK Cells Activity of CHC Patient Treated by DAAs

NCT03188276

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Not specified

View Trial Details